Long COVID : Does SARS‐CoV ‐2 induce lingering brain lesions?
European Journal of Neurology · 2023
DOI: 10.1111/ene.15751 ↗At a glance
Editorial in European Journal of Neurology, 2023. Written by Jacques Hugon. Institution: Cognitive Neurology Center, University of Paris City Lariboisière Hospital APHP, Paris, France. Major MEDLINE topics: COVID-19, Nervous System Diseases. Cited 2 times so far (Crossref); 10 references.
Abstract (original language)
Hundreds of millions of COVID cases have been reported so far and long‐term lingering clinical symptoms are frequent and are called long COVID. Neurological signs including cognitive complaints are often described in long Covid. In COVID patients, the Sars‐Cov‐2 virus can reach the brain and could be responsible for cerebral anomalies observed in long COVID. Long‐term careful clinical follow‐up of these patients is necessary to detect early signs of neurodegeneration.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Cognitive Neurology Center, University of Paris City Lariboisière Hospital APHP, Paris, France.
Cite
APA
Hugon, J. (2023). Long COVID : Does SARS‐CoV ‐2 induce lingering brain lesions?. European Journal of Neurology. https://doi.org/10.1111/ene.15751
Vancouver
Hugon J. Long COVID : Does SARS‐CoV ‐2 induce lingering brain lesions?. European Journal of Neurology. 2023. doi:10.1111/ene.15751
BibTeX
@article{Hugon2023,
author = {Hugon, Jacques},
title = {Long COVID : Does SARS‐CoV ‐2 induce lingering brain lesions?},
journal = {European Journal of Neurology},
year = {2023},
doi = {10.1111/ene.15751}
}
EUVIMED